Master
Content
Clinical trials - also known as clinical studies or research protocols - are conducted to test whether a new drug, new prevention strategy, or new screening test is safe and effective in people. Participation is always voluntary. Baylor College of Medicine investigators conduct hundreds of studies, ranging from small, short-term studies to large trials with thousands of patients across many institutions.
Content
View Actively Recruiting Studies at Baylor College of Medicine trials on ClinicalTrials.gov.
Search for Clinical Trials
Phase I study of HER2 chimeric antigen receptor (CAR) T cells in combination with checkpoint blockade in patients with advanced sarcoma (HEROS 3.0)…
The purpose of this study is to find the largest safe dose of TAA-specific CTLs, to learn what the side effects are, and to see whether this therapy…
This research study uses special immune system cells called AGAR T cells, a new experimental treatment.
This study is a first in human Phase 1 study that involves patients with a type of cancer called HER2 (Human Epidermal Growth Factor Receptor 2)…
The purpose of this study is to find out the highest safe dose of allogeneic CD30.CAR-EBVST cells given following chemotherapy and used to treat…
In this study, investigators attach the CD7 chimeric receptor with CD28 added to it to T cells that have had CD7 removed from their surface.
This is a Phase III, multicenter, randomized study with two arms (1:1 ratio) enrolling patients with AML relapsed/refractory after 2 or 3 prior…
The primary objective of this phase 1, first in man trial is to determine the safety, toxicity, and feasibility of delivering autologous dendritic…
This study is for patients who have lymphoma or leukemia that has come back or has not gone away after treatment.
Phase I study of autologous T lymphocytes expressing GD2-specific chimeric antigen and constitutively active IL-7 receptors for the treatment of…
